Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Method of Enhancing Opsonophagocytosis
Case ID:
TAB-2650
Web Published:
12/6/2022
This invention aims to bolster the human body's own mechanisms to fight infection by enhancing an innate immune response, opsonophagocytosis. The specific 24 amino acid sequence (P4) acts as a polymorphonuclear cell activator. P4 can be administered in vivo along with a disease's specific antibody to enhance systemic bacterial clearance, thus leading to prolonged survival. This technology enhances the body's response to infections such as
S. pneumoniae
and
S. aureus
.
Patent Information:
Title
App Type
Country
Serial No.
Patent No.
File Date
Issued Date
Expire Date
Direct Link:
https://canberra-ip.technologypublisher.com/tech/Method_of_Enhancing_Opsonoph agocytosis
Keywords:
ANTIGEN
CDC Docket Import
CDC Docket Import CDC Prosecuting
DA3XXX
DAXXXX
DB3XXX
DB5XXX
DBXXXX
DC1XXX
DC4XXX
DCXXXX
DXXXXX
ENHANCING
Epitopes
FUNCTIONAL
Listed LPM Surabian as of 4/15/2015
Methods
OID-NCIRD-DBD
Opsonophagocytosis
PATHOGEN
PNEUMONIAE
Post LPM Assignment Set 20150420
Pre LPM working set 20150418
PsaA
RESPONSE
Streptococcus
THEREOF
USES
Bookmark this page
Download as PDF
For Information, Contact:
Jonathan Motley
Fellow
NIH Technology Transfer
jonathan.motley@nih.gov